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htcense.Abstract Background: Ultrasonographic (US) examination is an accurate method for detecting
thyroid nodules, but its use in differentiating between benign and malignant thyroid nodules is rel-
atively low. US elastography has been applied to study the hardness/elasticity of nodules to differ-
entiate malignant from benign lesions thus deviating a signiﬁcant group of patients from
unnecessary FNAB.
Objectives: The aim of the study is to evaluate the validity of combined grey scale US and tissue
elastography in differentiating benign form malignant solid thyroid nodules.
Methods: The study included 46 selected patients with solid thyroid nodules according to our inclu-
sion and exclusion criteria. The patients underwent surgery for compressive symptoms or suspicion
of malignancy on FNA cytology. US features and tissue elastography were scored according to the
Rago criteria (1).
Results: On US elastography: all the 31 cases with a ﬁnal diagnosis of benign nodule had a score of
1–3, while 14 of 15 (94.1%) with a ﬁnal diagnosis of carcinoma had a score of 4–5, with a sensitivity
of 93.3%, a speciﬁcity of 100% and an accuracy of 97.8%. Combined US and elastography reveals
that hypoechogenicity/score 4–5 was most predictive of malignancy with sensitivity 80% and spec-
iﬁcity 100%; and accuracy 93.4%.
Conclusions: US elastography seems to have great potential as a new tool for differentiating solid
thyroid nodules and for recommending FNAC. Combined grey scale US features and US elastog-
raphy added no signiﬁcant value when compared with US elastography alone. Further prospective
studies are needed.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.5039809.
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The prevalence of thyroid nodules is about 3–8% in the gen-
eral population (2–5) and is greater than 50% after age of
65 years (2). Most thyroid nodules are benign, with 5–15%
being malignant (7). The challenge of managing thyroidgyptian Society of Radiology and Nuclear Medicine.
3.04.008
506 N. Mohey et al.nodules is to reassure patients with benign disease and to diag-
nose patients with malignant disease (6). A ﬁrm and hard thy-
roid nodule on palpation is associated with an increased risk of
malignancy. Palpation is subjective and highly dependent on
the examiner and on the size and location of the nodules (8).
Ultrasonographic (US) examination is an accurate method
for detecting thyroid nodules, but its use in differentiating be-
tween benign and malignant thyroid nodules is relatively low
(2). Fine-needle aspiration (FNA) is the standard procedure
to determine whether a thyroid nodule is cancerous. However,
FNA is an invasive procedure, and about 10–20% of FNAs
yield inadequate results and lead to repeat biopsy (4). Palpa-
tion has been used in clinical examination to assess the degree
of ﬁrmness of a thyroid nodule. However, palpation is a sub-
jective method, and the assessment varies depending on the
size and location of the nodule and on the examiner (5).
Indeed, as compared with FNA, thyroid US has the advan-
tage of being a noninvasive procedure giving immediate infor-
mation. Among several US patterns, hypoechogenicity of the
nodule, spot microcalciﬁcations, and the absence of halo sign
have been useful for predicting thyroid malignancy (9,10).
However no ultrasound feature has both high sensitivity and
high speciﬁcity in detecting malignancy of thyroid nodules (6).
Ultrasonographic (US) elastography (sonoelastography) is
a noninvasive imaging technique that can be used to depict rel-
ative tissue stiffness or displacement (strain) in response to an
imparted force. Stiff tissues deform less and exhibit less strain
than compliant tissues in response to the same applied force.
Thus, the basis of elastography is analogous to manual palpa-
tion (1,11). The application of US elastography for imaging
tissues is relatively novel, ﬁrst described in 1987 by Krouskop
et al. (12).
Elastography is a newly developed dynamic technique that
usesUS to provide an estimation of tissue stiffness bymeasuring
the degree of distortion under the application of an external
force. US is applied to study the hardness/elasticity of nodules
to differentiate malignant from benign lesions. A recent report
on thyroid nodules concluded thatUS elastographymay predict
malignancy in a score of 4–6 with a sensitivity of 89.3%, a spec-
iﬁcity of 88.2% and an accuracy of 88.9% (6)
2. Patients and methods
The study included 70 patients with solid thyroid nodule on
grey scale US, and 24 patients were excluded according to
our exclusion criteria, so the total number of selected patients
were 46 patients (31 females, mean age of 43 years, and 15
males, mean age of 39 years), seen from January 2011 till Jan-
uary 2013.
*Inclusion criteria by grey scale US: any solid thyroid nod-
ule included in a total of 70 patients
*Exclusion criteria by grey scale US:
1. Cystic thyroid nodules (6 patients).
2. Calciﬁed shell thyroid nodules (10 patients).
3. Coalescent nodules in multinodular Goitre (8 patients).
The selected 46 patients underwent surgery for compressive
symptoms or suspicion of malignancy on FNA cytology. Ap-
proval of the medical ethics committee was obtained and all
patients gave their informed consent prior to the study. Serumcalcitonin was undetectable in the 46 patients. All patients
were euthyroid. FNA was performed under US guidance by
a skilled radiologist using a 23-gauge needle attached to a
10 ml syringe. The material was sent for histological examina-
tion by an experienced cytologist.
**The indications for surgery were:
1. Large size nodule with benign cytology (12 patients) for
cosmetic reason because of disﬁgurement.
2. An indeterminate FNAC (16 patients).
3. Non diagnostic cytology (6 patients).
4. A cytological diagnosis suggestive (in 7 patients) or suspi-
cious (in 4 patients) of papillary carcinoma.
5. Suspected medullary carcinoma in one case.
2.1. Thyroid conventional US and US elastography
Thyroid US and US elastography were performed using a real-
time ultrasound (GE LOGIQ P6, using linear high frequency
probe with frequency of 10 MHz, GE Medical Systems,
USA). A careful evaluation of the following US parameters
was performed on all thyroid nodules: echogenicity (hyperech-
oic, isoechoic, or hypoechoic with respect to normal thyroid
parenchyma), presence or absence of the halo sign; spot micro-
calciﬁcations (presence of hyperechoic spots less than 2 mm,
without acoustic shadowing); and colour ﬂow Doppler pattern
that was deﬁned as the absence of blood ﬂow (type I), perino-
dular and absent or slight intranodular blood ﬂow (type II),
and marked intranodular and absent or slight perinodular
blood ﬂow (type III) (9). US elastography was performed dur-
ing the US examination, using the same machine and the same
probe. The probe was placed on the neck with light pressure,
and a box was highlighted by the operator that included the
nodule to be evaluated. In the case of multiple nodules, each
nodule is evaluated separately. The principle of US elastogra-
phy is to acquire two ultrasonic images (before and after tissue
compression by the probe) and track tissue displacement by
assessing the propagation of the imaging beam. A scale is
available on the machine to measure if adequate compression
was used (Fig. 1). The US elastogram was displayed over the
B-mode image in a colour scale that ranges from red, for com-
ponents with greatest elastic strain (i.e. softest components), to
blue for those with no strain (i.e. hardest components) (Fig. 2).
The elastograms thus obtained were classiﬁed according to the
scores by Rago et al. (1). Elasticity according to Rago et al. (1)
(thereafter, Rago criteria) originated from the elastography
scale by Ueno et al. (13) and was applied to thyroid nodules
and elastography scores were classiﬁed on a scale of 1 to 5
(Fig. 2). Nodules with Rago scores of 4 and 5 were classiﬁed
as suspicious for malignancy (Table 1 and Fig. 2). It is impor-
tant that the level of pressure is maintained constant through-
out the examination (see Figs. 3–5).
All examinations were performed by the same operator,
who was not aware of the results of cytology. Static and mov-
ing images were also recorded to be reviewed subsequently by
a second skilled US examiner. The agreement on the scoring of
US parameter was more than 92% between the two observers.
In particular, scoring by the two examiners was coincident in
42 of 46 patients. In four cases the ﬁnal score was agreed after
conjoint re-examination of the recorded movies.
Fig. 1 Showing the automated calibrated compression scale (white head) (a) the scale is not totally full so inadequate, (b) the scale is full
so the images can be interpreted. Colour scale (white arrow) that ranges from red (i.e. softest components), to blue (i.e. hardest
components).
Fig. 2 Elastogrphy scores according to Rago criteria (quoted from 8).
Table 1 Elasticity score (1,15).
Score
1 Elasticity in the whole nodule
2 Elasticity in a large part of the nodule
3 Elasticity only at the peripheral part of the nodule
4 No elasticity in the nodule
5 No elasticity in the nodule and in the posterior shadowing
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3.1. Histology
Of 46 cases, 15 (32.6%) had a ﬁnal diagnosis of malignancy on
histology: 13 papillary thyroid carcinomas, including 8 classic
variants, four follicular variants, and one tall cell variant; one
minimally invasive follicular carcinoma; and one medullary
carcinoma. Of 46 nodules, 31 (67.4%) were benign at histol-
ogy: 24 follicular adenomas, 6 hyperplastic nodules, and one
oxyphilic adenoma.
3.2. Grey scale US
Nodule hypoechogenicity (sensitivity 80% and speciﬁcity
61.2%; accuracy 67.4), absent halo sign (sensitivity 40% and
speciﬁcity 19.3%; accuracy 26.1%), spot microcalciﬁcations
(sensitivity 66.7% and speciﬁcity 70.9%; 69.5%) were the US
patterns most predictive of malignancy. The pattern ofintranodular blood ﬂow, taken alone, was not predictive of
malignancy (sensitivity 6.7% and speciﬁcity 96.7%; accuracy
67.4) (Table 2). The absence of halo sign combined with the
presence of spot microcalciﬁcations as well as absent halo
sign/hypoechogenicity was most predictive of malignancy (sen-
sitivity 60% and speciﬁcity 93.5%; and accuracy 78.3% and
82.6% respectively) (Table 3).
3.3. US elastography
On US elastography: score 1 was found in 21 cases, all benign
lesions; score 2 in 4 cases, all benign; score 3 in 7 cases, 6 be-
nign and one carcinoma; score 4 in 2 cases, all carcinomas
and score 5 in 12 cases; all carcinomas (Table 4).
Thus, all 31 cases with a ﬁnal diagnosis of benign nodule
had a score of 1–3, while 14 of 15 (94.1%) with a ﬁnal diagno-
sis of carcinoma had a score of 4–5, with a sensitivity of
93.3%, a speciﬁcity of 100% and an accuracy of 97.8%
(Table 4). One of the 15 nodules with the histological diagnosis
of papillary cancer had a score of 3.
Among benign lesions, the score was 1 in 4 and 2 in 2 of the
6 hyperplastic nodules; it was 1 in17, 2 in 2, and 3 in 6 of the 25
adenomatous nodules. Although the number of hyperplastic
nodules is too small to allow a reliable statistical evaluation,
these data suggest that adenomatous nodules have a higher
stiffness with respect to the hyperplastic nodules.
Combined US ﬁndings and US elastography reveals that
hypoechogenicity/score 4–5 was most predictive of malignancy
with sensitivity 80% and speciﬁcity 100%; and accuracy 93.4%
in addition to the presence of spot microcalciﬁcations/score
Fig. 3 Forty one year-old female patient with solitary right thyroid nodule proved to be papillary adenoma by histopathology: (A)
Colour Doppler study revealed type II vascularization. (B) Grey scale US showing hypoechoic nodule with halo sign (C) US elastography
reveals elasticity score 2.
Fig. 4 Forty seven year-old female patient with solitary isthmic
thyroid nodule proved to be papillary adenoma by histopathol-
ogy: (A) grey scale US showing hypoechoic nodule with absent
halo sign, (B) US elastography reveals elasticity score 1.
Fig. 5 Thirty seven year-old female patient with solitary isthmic
thyroid nodule proved to be Follicular carcinoma: (A) US
showing hypoechoic nodule with halo sign, (B) US elastography
reveals elasticity score 5.
508 N. Mohey et al.4–5 with sensitivity 66.7% and speciﬁcity 100%; and accuracy
89.1% in addition to absent halo sign/score 4–5 with sensitivity
60% and speciﬁcity 96.7%; and accuracy 84.7% (Table 5).
Of the 16 patients with a FNA result of indeterminate (fol-
licular) lesion, 12 had a benign follicular adenoma on histology
and 4 a carcinoma: one papillary, classic variant; two papillary
follicular variants; and one minimally invasive follicular carci-
noma. The conventional US, as previously shown in a larger
series of patients (14), was not predictive in these patients.
At variance, an US elastography score of 4–5 was observed
in 3 of 4 (75%) patients with carcinoma and a score of 1–3 in
all 13 patients, 12 of them with benign lesions and one was
malignant (Table 6).
4. Discussion
There is a general agreement that ultrasound features indicat-
ing a high risk for malignancy should be an indication for anFNAB and even further treatment such as surgery. Ultrasound
features predictive of malignant nodules include the presence
of irregular margins, marked hypoechogenicity, microcalciﬁca-
tions, taller-than-wide shape, and intranodular vascularity
(6,7,15).
Sensitivity, speciﬁcity, PPV and NPV for these criteria are
extremely variable from one study to the other (16). Our study
revealed that nodule hypoechogenicity (sensitivity 80% and
speciﬁcity 61.2%; P 0.008), absent halo sign (sensitivity 40%
and speciﬁcity 19.3%; P 0.008), spot microcalciﬁcations (sensi-
tivity 66.7% and speciﬁcity 70.9%; P 0.01) were the US pat-
terns most predictive of malignancy in agreement with Rago.
Another recent study (6) revealed that ill-deﬁned margins, spot
microcalciﬁcations and AP/T diameter more than 1 cm were
the most predictive ultrasound patterns of malignancy.
In the present study, absence of halo sign combined with
the presence of spot microcalciﬁcations as well as absent halo
sign/hypoechogenicity were most predictive of malignancy
Table 2 Sensitivity, speciﬁcity and accuracy US patterns in histopathologically proved thyroid nodules.
BN (n= 31) CA (N= 15) P value Sensitivity (%) Speciﬁcity (%) Accuracy
Hypoechogenicity 0.008** 80.0 61.2 67.4
Present 12 12
Absent 19 3
Halo sign 0.008** 40.0 19.3 26.1
Present 25 6
Absent 6 9
Spot microcalciﬁcations 0.01** 66.7 70.9 69.5
Present 9 10
Absent 22 5
Type III vascularization 1.0 6.7 96.7 67.4
Present 1 1
Absent 30 14
** P< 0.01 highly signiﬁcant.
Table 3 Sensitivity, speciﬁcity and accuracy of combination of US patterns in histopathologically proved thyroid nodules.
BN (n= 31) CA (N= 15) P value Sensitivity
(%)
Speciﬁcity
(%)
Accuracy
(%)
Absent halo sign/Hypoechogencity 0.000 60.0 93.5 78.3
Both Present 2 9 1**
One Absent 29 6
Absent halo sign/spot microcalciﬁcations 0.0001** 60.0 93.5 82.6
Both Present 2 9
One Absent 29 6
Hypoechogenicity/spot microcalciﬁcations 0.002** 53.3 90.3 78.2
Both Present 3 8
One Absent 28 7
Absent halo sign/hypoechogenicity/type III vascularization 0.32 6.7 100.0 69.4
Both Present 0 1
One Absent 31 14
Hypoechogenicity/spot microcalciﬁcations/type III vascularization 0.32 6.7 100.0 69.4
Both Present 0 1
One Absent 31 14
Absent halo sign/spot microcalciﬁcations/type III vascularization 0.32 6.7 100.0 69.4
Both Present 0 1
One Absent 31 14
** P> 0.05 not signiﬁcant, P< 0.05 signiﬁcant, P< 0.01 highly signiﬁcant.
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with (1) who stated that combined US features and colourTable 4 Distribution of elasticity scores in the study group
patients.
Elasticity score BN
(n= 31)
CA
(N= 15)
Sensitivity
(%)
Speciﬁcity
(%)
Accuracy
Score 1 21 –
Score 2 4 –
Score 3 6 1
Score 4 – 2
Score 5 – 12
Score 1–3 31 1 93.3 100.0 97.8
Score 4–5 – 14Doppler become highly predictive of malignancy only when
multiple patterns are simultaneously present in a thyroid
nodule.
Conventional US does not provide information regarding
hardness of the nodule and this is the role of USE (6). US elas-
tography was developed to determine tissue stiffness and strain
information noninvasively (17–19). Strain represents the
amount of deformation; thus, stiff tissue shows less strain than
softer tissue. A thyroid lesion may have different levels of stiff-
ness within it, depending on the cellularity and the composi-
tion of the nodule. Information from these elastograms helps
to assess the relative stiffness of the lesion compared with its
surrounding tissues and within itself (2).
Several previous studies have used ultrasound elastography
for evaluation of thyroid nodules (6). Many of them reported
variable sensitivity and speciﬁcity of USE for predicting
Table 5 Sensitivity, speciﬁcity and accuracy of combined US and US elastography in histopathologically proved thyroid nodules.
BN (n= 31) CA (N= 15) P value Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Absent halo sign/score 4-5 0.000 60.0 96.7 84.7
Both Present 1 9
One Absent 30 6
Present halo sign/score 1–3 0.008 40.0 19.3 26.1
Both Present 25 6
One Absent 6 9
Hypoechogenicity/score 4–5 0.000 80.0 100.0 93.4
Both Present 0 12
One Absent 31 3
Absent hypoechogenicity/score 1–3 0.000 6.7 38.7 28.3
Both Present 19 1
One Absent 12 14
Spot microcalciﬁcations/score 4–5 0.000 66.7 100.0 89.1
Both Present 0 10
One Absent 31 5
Absent Spot microcalciﬁcations/score 1–3 0.000 6.7 29.0 21.7
Both Present 22 1
One Absent 9 14
Type III vascularization/score 4–5 0.32 6.7 100.0 69.5
Both Present 0 1
One Absent 31 14
P< 0.01 (H.S) P> 0.05 (NS).
Table 6 Sensitivity, speciﬁcity and accuracy of combined US and US elastography in 16 patients with indeterminate thyroid nodules
on FNA.
BN (n= 12) CA (N= 4) P value Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Hypoechogenicity 1.0 75.0 41.6 50.0
Present 7 3
Absent 5 1
Halo sign 1.0 100.0 8.3 31.2
Present 11 4
Absent 1 0
Spot microcalciﬁcations 1.0 25.0 75 62.5
Present 3 1
Absent 9 3
Type III vascularization 1.0 0.0 91.6 68.7
Present 1 0
Absent 11 4
Score 1–3 on US elastography 12 1 0.007 75.0 100.0 93.7
Score 4–5 on US elastography 0 3
510 N. Mohey et al.malignancy. Lyshchik et al. (20) reported 82% sensitivity and
96% speciﬁcity, Rago et al. (1) reported sensitivity of 97% and
speciﬁcity of 100%,, Hong et al. (21) reported sensitivity of
88% and speciﬁcity of 90%, Rania and Khaled (6), reported
sensitivity of 89.3% and speciﬁcity of 82.2%.
The study included 46 selected patients with thyroid nod-
ules. In our study group, the highest elasticity scores, indicative
of a greater nodular consistency, were invariably associated
with malignancy (speciﬁcity 100%, sensitivity 93.3%, accuracy
97.8%) in agreement with (1,6). However, it is important to
note that the study group included selected patients with solidnodules in which thyroid surgery had been already planned be-
cause of cytological suspicion or large nodular size which
could represent a bias that ampliﬁes the predictive value of
US elastography.
In the present study the most US features suggestive of
malignancy were, absence of halo sign combined with the pres-
ence of spot microcalciﬁcations as well as combined absent
halo sign/hypoechogenicity (sensitivity 60% and speciﬁcity
93.5%; with accuracy 82.6% and 78.3% respectively) and all
were conﬁrmed by US elastography that revealed a score of
1–3 in all benign cases with only one case scored as score 3
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a follicular carcinoma.
Combined US ﬁndings and US elastography reveals that
hypoechogenicity/score 4–5 was most predictive of malignancy
with sensitivity 80% and speciﬁcity 100%; and accuracy 93.4%
followed by the presence of spot microcalciﬁcations/score 4–5
with sensitivity 66.7% and speciﬁcity 100%; and accuracy
89.1%.
These results revealed that combined techniques were
superior to US alone and added no signiﬁcant value when
compared with US elastography alone in agreement with
(8) study that revealed that the combination of elastography
and grey-scale US, showed inferior performance in differen-
tiating malignant and benign thyroid nodules. But we dis-
agree with (8) who mentioned that US elastography alone
shows inferior performance when compared with grey-scale
US features. We think this controversy may be explained
by many limitations in (8) study, one of them was that
about half of the nodules in the mentioned study were not
surgically correlated.
Although presently, FNA remains the most important pro-
cedure for the diagnostic management of thyroid nodules, yet
a substantial proportion (up to 20%) of cytological specimens
yields indeterminate results (22) and the distinction between
benign and malignant lesions can only be made on histological
criteria.
In follicular lesions, conventional echographic patterns
were found to be of minor relevance for predicting carcinoma
in agreement with (14). These results have been conﬁrmed in
the present series of 16 patients with indeterminate nodules
on cytology, 7 of whom resulted to have a papillary or follic-
ular thyroid carcinoma on histology. The predictivity of US
elastography in this subgroup of patients was rewarding,
scores 4–6 being found in 3 of 4 patients having a ﬁnal diagno-
sis of malignancy and a score of 1–3 in all 12 patients with a
histological diagnosis of benign lesion.
On the other hand, conventional US maintains a pivotal
importance to deﬁne which nodules are suitable for the US
elastographic characterization in agreement with (22).
Nodules in which US reveals the presence of calciﬁed shell
were excluded from the US elastographic evaluation because
the US beam does not cross the calciﬁcation, and the probe
compression does not result in tissue strain deformation. Sim-
ilarly, in cystic nodules, US elastography cannot give useful
information, the main determinant of nodule stiffness being
the ﬂuid content, and not the solid wall. For this reason, we
selected 46 patients who had solid nodules for the analysis in
agreement with (10).
We also excluded cases with multinodular goitres with coa-
lescent nodules in agreement with (10) because the nodule to
be examined must be clearly distinguishable from other nod-
ules present in the thyroid, to select it for the US elastography
measurement.
5. Conclusion
US elastography seems to have great potential as a new tool
for differentiating solid thyroid nodules and for recommending
FNAC. Combined grey scale US features and US elastography
added no signiﬁcant value when compared with US elastogra-
phy alone. Further prospective studies are needed.References
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